Edwards has been advancing the care of the acutely ill for more than 40 years. Starting with the development of advanced haemodynamic monitoring devices for measuring cardiovascular performance in high-risk surgical and critically ill patients, Edwards continues to evolve to less-invasive and non-invasive devices to provide valuable haemodynamic insight for an expanded patient population.
Edwards has continued to advance haemodynamic monitoring platforms to enable proactive clinical decisions for surgical, anaesthesia and critical care clinicians. Edwards is focused on helping clinicians enhance knowledge and standardise practice to improve the quality and efficiency of care.
Edwards provides evidence-based programs such as Enhanced Surgical Recovery Program that support the implementation and compliance to protocolised care pathways in the OR and ICU.
In this Edwards Virtual Physiology Lab event, review practical and physiological concepts of haemodynamic monitoring across the perioperative and critical care continuum.
There will also be a demonstration of the application of the Acumen Hypotension Prediction Index (HPI) software in a variety of physiological conditions and clinical settings.
This webinar featured speakers, Dr Simon Davies, Professor Monty Mythen, and Associate Professor Laurence Weinberg.
Watch our latest presentations, clinical refreshers and instructional videos for your surgical and critical care patients.
Edwards Lifesciences’ roots date to 1958, when Miles “Lowell” Edwards set out to build the first artificial heart.
Edwards was a 60-year-old, recently retired engineer holding 63 patents in an array of industries, with an entrepreneurial spirit and a dream of helping patients with heart disease.
At Edwards Lifesciences, we are dedicated to providing innovative solutions for people fighting cardiovascular disease.